DHR vs SLB: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and SLB N.V. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
Danaher Corporation ยท Healthcare
$177.17
+8.9% upside to fair value
Grade B High Quality
VS
SLB N.V. ยท Energy
$48.09
-33.4% upside to fair value
Grade C
QuantHub Verdict
DHR has more upside to fair value (+8.9%). SLB trades at a lower forward P/E (21.8x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric DHR SLB
Current Price $177.17 $48.09
Fair Value Estimate $192.90 $32.01
Upside to Fair Value +8.9% -33.4%
Market Cap $125.4B $71.9B
Forward P/E 34.1x 21.8x
EV / EBITDA 20.8x 10.9x
Price / Sales 5.1x 2.0x
Price / FCF 23.7x 15.4x
Revenue Growth YoY +3.7% +2.7%
Gross Margin 60.7% 17.3%
Operating Margin 21.0% 14.4%
Return on Equity 7.1% 13.5%
Dividend Yield 0% 0%
FCF Yield 4.22% 6.51%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
DHR โ€” Danaher Corporation
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth ofโ€ฆ
SLB โ€” SLB N.V.
SLB N.V. is a global leader in oilfield services, specializing in well construction, production systems, reservoir performance, and digital solutions. The company benefits from a durable competitive moat anchored in technology, integrated service breadth, and global infrastructure, with a management team that has long tenure and deep industry experience. Despite solid free cash flow generation ofโ€ฆ
Accumulation Zones
Metric DHR SLB
Zone Low $144.68 $24.01
Zone High $163.97 $27.21
In Buy Zone? No No
โ† DHR Research    SLB Research โ†’    All Research